Latest ebit for 4161.TWO: $75M, below the sector sector average of $2.3T.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2026
Trailing 12 months ending Sep 30, 2026
Bioptik Technology Incorporation (4161.TWO) currently reports a EBIT of $75M as of September 2026. That compares with $99M in the prior-year period — down 24.5% year over year. That is below the sector sector average of $2.3T. Use the charts on this page to explore Bioptik Technology Incorporation's EBIT history and peer comparisons.
Bioptik Technology Incorporation's EBIT decreased from $99M to $75M — a 24.5% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Bioptik Technology Incorporation's EBIT of $75M is lower than the its sector sector average of $2.3T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Bioptik Technology Incorporation reported $75M in EBIT as of September 2026. That compares with $99M in the prior-year period — down 24.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $75M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.3T. From there, open related valuation or income-statement pages for Bioptik Technology Incorporation, and consider following 4161.TWO for alerts when major investors trade the stock.